DHAKA, BANGLADESH - Media OutReach Newswire - 10 January 2025 - The Best Places to Work certification program has recognized Foodpanda ...

Foodpanda, a leading online food delivery platform, has earned the top spot in Bangladesh for its dedication to fostering a ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

The dominance of the US, and its technology companies in particular, has become an accepted feature of global stock markets.

A UK biotechnology startup is entering the crowded obesity drug market, armed with $411 million and a promising ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.

BBI Solutions Limited ("BBI"), global leader in the development and manufacture of IVD reagents, announces a CEO succession. After 7 years as ...

Novo Nordisk shares fell nearly 30% in the fourth quarter on disappointing clinical trial data, and other concerns. Bank of ...

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss drug ...

Variant Bio is partnering with Novo Nordisk to study metabolic diseases including obesity, using Variant's genomic data from ...

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...